Bidchol Abdul Mueed, Dalal Ashwin, Trivedi Rakesh, Shukla Anju, Nampoothiri Sheela, Sankar V H, Danda Sumita, Gupta Neerja, Kabra Madhulika, Hebbar Shrikiran A, Bhat Ramesh Y, Matta Divya, Ekbote Alka V, Puri Ratna Dua, Phadke Shubha R, Gowrishankar Kalpana, Aggarwal Shagun, Ranganath Prajnya, Sharda Sheetal, Kamate Mahesh, Datar Chaitanya A, Bhat Kamalakshi, Kamath Nutan, Shah Hitesh, Krishna Shuba, Gopinath Puthiya Mundyat, Verma Ishwar C, Nagarajaram H A, Satyamoorthy Kapaettu, Girisha Katta Mohan
Department of Medical Genetics, Kasturba Medical College, Manipal University, Manipal, Karnataka, India.
Diagnostics Division, Centre for DNA Fingerprinting and Diagnostics, Hyderabad, Telangana, India.
Gene. 2015 Aug 10;567(2):173-81. doi: 10.1016/j.gene.2015.04.078. Epub 2015 Apr 30.
GM1 gangliosidosis is a lysosomal storage disorder caused by mutations in the GLB1 gene, leading to the deficiency of the enzyme β-d-galactosidase. In this study, we report molecular findings in 50 Asian Indian families with GM1 gangliosidosis. We sequenced all the exons and flanking intronic sequences of GLB1 gene. We identified 33 different mutations (20 novel and 13 previously reported). The novel mutations include 12 missense (p.M1?, p.E129Q, p.G134R, p.L236P, p.G262E, p.L297F, p.Y331C, p.G414V, p.K493N, p.L514P, p.P597L, p.T600I), four splicing (c.246-2A>G, c.397-2A>G, c.552+1G>T, c.956-2A>G), three indels (p.R22Qfs8, p.L24Cfs47, p.I489Qfs4) and one nonsense mutation (p.Q452). Most common mutations identified in this study were c.75+2InsT (14%) and p.L337P (10%). Known mutations accounted for 67% of allele frequency in our cohort of patients, suggesting that these mutations in GLB1 are recurrent across different populations. Twenty three mutations were localized in the TIM barrel domain, β-domain 1 and β-domain 2. In silico sequence and structure analysis of GLB1 reveal that all the novel mutations affect the function and structure of the protein. We hereby report on the largest series of patients with GM1 gangliosidosis and the first from India.
GM1神经节苷脂贮积症是一种溶酶体贮积病,由GLB1基因突变引起,导致β - d - 半乳糖苷酶缺乏。在本研究中,我们报告了50个患有GM1神经节苷脂贮积症的亚洲印度家庭的分子研究结果。我们对GLB1基因的所有外显子和侧翼内含子序列进行了测序。我们鉴定出33种不同的突变(20种新突变和13种先前报道的突变)。新突变包括12种错义突变(p.M1?、p.E129Q、p.G134R、p.L236P、p.G262E、p.L297F、p.Y331C、p.G414V、p.K493N、p.L514P、p.P597L、p.T600I)、4种剪接突变(c.246 - 2A>G、c.397 - 2A>G、c.552 + 1G>T、c.956 - 2A>G)、3种插入缺失突变(p.R22Qfs8、p.L24Cfs47、p.I489Qfs4)和1种无义突变(p.Q452)。本研究中鉴定出的最常见突变是c.75 + 2InsT(14%)和p.L337P(10%)。已知突变在我们的患者队列中占等位基因频率的67%,这表明GLB1基因中的这些突变在不同人群中具有复发性。23种突变位于TIM桶结构域、β结构域1和β结构域2中。对GLB1的计算机序列和结构分析表明,所有新突变均影响蛋白质的功能和结构。我们在此报告了最大系列的GM1神经节苷脂贮积症患者,且是来自印度的首个此类报告。